NCT00004110 2013-10-31
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
5 trialsNCT00002560 2013-06-28
Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00002458 2013-06-05
Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00040872 2013-03-07
Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00089258 2013-01-17
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Completed